Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hargreaves Lansdown PLC Director's Dealing 2019

Apr 17, 2019

4868_dirs_2019-04-17_5c6aa036-3e6b-4b4a-9d5e-e18cf71504cc.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5453W

Hargreaves Lansdown PLC

17 April 2019

Hargreaves Lansdown plc

DIRECTOR/PDMR SHAREHOLDING - GRANT OF AWARDS

17th April 2019

On 15th April 2019, David James, Marketing Director, was granted the following options over Hargreaves Lansdown plc Ordinary Shares.

Number of Shares subject to option Option Price Vesting date Arrangement
3,539 Nil cost 30th June 2019 Listing Rule 9.4.2 arrangement
2,653 Nil cost 17th November 2019 Listing Rule 9.4.2 arrangement
5,703 Nil cost 26th June 2020 Listing Rule 9.4.2 arrangement
2,317 Nil cost 26th June 2021 Listing Rule 9.4.2 arrangement

The nil-cost options will become exercisable on vesting dates shown above, subject to continuous employment with Hargreaves Lansdown plc.

Buy-Out Awards

The nil-cost options were awarded to Mr James under an arrangement to which Listing Rule 9.4.2 applies in respect of the buy-out of the share option arrangements Mr James forfeited on leaving his previous employment. 

The Remuneration Committee believes that the award fairly reflects the value of awards Mr James forfeited on leaving his previous employment in terms of value and timescale of vesting.

This announcement is made in accordance with the requirements of DTR 3.1.4.

For further information please contact:

Hargreaves Lansdown +44 (0)117 906 7824

Alison Zobel, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHEDLFFKZFEBBB